NM_024675.4(PALB2):c.3202-13T>C AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Feb 9, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003596262.1

Allele description [Variation Report for NM_024675.4(PALB2):c.3202-13T>C]

NM_024675.4(PALB2):c.3202-13T>C

Gene:

PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16p12.2

Genomic location:

Preferred name:

NM_024675.4(PALB2):c.3202-13T>C

HGVS:

NC_000016.10:g.23608025A>G
NG_007406.1:g.38333T>C
NM_001407296.1:c.3142-13T>C
NM_001407297.1:c.3130-13T>C
NM_001407298.1:c.3040-13T>C
NM_001407299.1:c.3114-4356T>C
NM_001407300.1:c.2923-13T>C
NM_001407301.1:c.3202-4356T>C
NM_001407302.1:c.3040-4356T>C
NM_001407304.1:c.2317-13T>C
NM_001407305.1:c.2317-13T>C
NM_001407306.1:c.2317-13T>C
NM_001407307.1:c.2155-13T>C
NM_001407308.1:c.2229-4356T>C
NM_001407309.1:c.2229-4356T>C
NM_001407310.1:c.2317-4356T>C
NM_001407311.1:c.2317-4356T>C
NM_001407312.1:c.1414-13T>C
NM_001407313.1:c.1414-4356T>C
NM_001407314.1:c.736-13T>C
NM_024675.4:c.3202-13T>CMANE SELECT
LRG_308:g.38333T>C
NC_000016.9:g.23619346A>G
NM_024675.3:c.3202-13T>C

Molecular consequence:

NM_001407296.1:c.3142-13T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407297.1:c.3130-13T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407298.1:c.3040-13T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407299.1:c.3114-4356T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407300.1:c.2923-13T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407301.1:c.3202-4356T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407302.1:c.3040-4356T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407304.1:c.2317-13T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407305.1:c.2317-13T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407306.1:c.2317-13T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407307.1:c.2155-13T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407308.1:c.2229-4356T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407309.1:c.2229-4356T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407310.1:c.2317-4356T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407311.1:c.2317-4356T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407312.1:c.1414-13T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407313.1:c.1414-4356T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407314.1:c.736-13T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_024675.4:c.3202-13T>C - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:: Fanconi anemia complementation group N
Identifiers:: MONDO: MONDO:0012565; MedGen: C1835817; Orphanet: 84; OMIM: 610832

Name:: Pancreatic cancer, susceptibility to, 3
Synonyms:: Pancreatic cancer 3
Identifiers:: MONDO: MONDO:0013236; MedGen: C3150547; Orphanet: 1333; OMIM: 613348

Name:: Breast-ovarian cancer, familial, susceptibility to, 5 (BROVCA5)
Identifiers:: MONDO: MONDO:0957530; MedGen: C5830615; OMIM: 620442

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004363645	Institute of Immunology and Genetics Kaiserslautern	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Feb 9, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004363645

Institute of Immunology and Genetics Kaiserslautern

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Feb 9, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Institute of Immunology and Genetics Kaiserslautern, SCV004363645.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

ACMG Criteria: PM2, Variant was found in heterozygous state

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine